Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Pine bark extract is rich in oligomeric proanthocyanidins (OPCs)—including catechin, taxifolin, and procyanidins B1–B3—that scavenge reactive oxygen species, inhibit NF-κB and COX-1/COX-2 pathways, and reduce pro-inflammatory cytokines TNF-α and IL-1β. A 2020 Cochrane systematic review (PMID 33141449) confirmed that phlebotonics including pine bark extract significantly improve venous insufficiency symptoms, while recent pharmacokinetic analysis (PMID 38757126) established that its bioactive metabolite M1 reaches peak plasma concentrations within 2–4 hours, supporting its systemic antioxidant, anti-inflammatory, and vasoprotective pine bark benefits.
Reported Benefits (Provisional)
Origin & History
Pine Bark, typically sourced from species like *Pinus pinaster* (Maritime Pine) or *Pinus densiflora* (Japanese Red Pine), is native to temperate and subtropical regions of Europe, North America, and Asia. It is highly valued in functional nutrition for its potent antioxidant and anti-inflammatory properties, primarily due to its rich proanthocyanidin content.
Research Narrative (Provisional)
A 2020 Cochrane systematic review by Martinez-Zapata et al. evaluated 53 randomized controlled trials and confirmed that phlebotonics, including pine bark extract (Pycnogenol®), significantly reduce edema and symptoms of chronic venous insufficiency compared to placebo (PMID 33141449). Liu et al. (2021) conducted the internet-based RADIANT randomized clinical trial demonstrating that a supplement combination containing pine bark extract improved hand pain outcomes in symptomatic hand osteoarthritis patients (PMID 33617972, Osteoarthritis and Cartilage). A 2022 systematic review and meta-analysis by Dutta et al. in Frontiers in Pharmacology evaluated phytotherapies including pine bark extract for ADHD, finding preliminary evidence of improved attention and hyperactivity scores in children, though further large-scale trials were recommended (PMID 35592415). Bayer et al. (2024) published a comprehensive pharmacokinetic review in Frontiers in Nutrition confirming that the key metabolite M1 (δ-(3,4-dihydroxyphenyl)-γ-valerolactone) achieves therapeutically relevant plasma levels within hours of oral Pycnogenol® ingestion (PMID 38757126).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Vitamins: Vitamin C - Phytochemicals: Proanthocyanidins, Polyphenols, Flavonoids, Tannins, Essential oils
Reported Mechanism (Provisional)
Pine bark extract's oligomeric proanthocyanidins (OPCs), particularly procyanidins B1–B3, catechin, and taxifolin, directly quench superoxide anion (O₂⁻), hydroxyl radicals (·OH), and peroxynitrite (ONOO⁻), protecting endothelial cell membranes from lipid peroxidation. These polyphenols inhibit the nuclear factor-kappa B (NF-κB) and activator protein-1 (AP-1) signaling cascades, thereby suppressing transcription of pro-inflammatory cytokines interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α). The extract also dose-dependently inhibits cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymatic activity and reduces matrix metalloproteinase-9 (MMP-9) release, which collectively protects collagen and elastin in vascular walls and dermal connective tissue. As confirmed by Bayer et al. (2024, PMID 38757126), the gut microbiota metabolizes OPCs into the bioactive catabolite M1 (δ-(3,4-dihydroxyphenyl)-γ-valerolactone), which accumulates in plasma and contributes significantly to systemic anti-inflammatory and endothelial-protective effects via enhanced nitric oxide (NO) bioavailability through endothelial nitric oxide synthase (eNOS) upregulation.
Clinical Narrative (Provisional)
Randomized controlled trials and meta-analyses demonstrate pine bark extract's efficacy in improving cardiovascular health, cognitive function, and skin elasticity. Clinical studies show the extract normalizes total antioxidant status and improves attention in children with ADHD, though specific quantified outcomes vary across studies. In vitro studies demonstrate approximately 98% reduction in Listeria species growth and significant inhibitory effects against E. coli O157:H7. While extensive research supports its antioxidant and anti-inflammatory properties, most quantified data derives from laboratory studies rather than large-scale human trials.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.